Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/cddis201293.

Title:
Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity | Cell Death & Disease
Description:
Cancer stem cells (CSCs) represent a population of cancer cells that possess unique self-renewal and differentiation characteristics required for tumorigenesis and are resistant to chemotherapy-induced apoptosis. Lung CSCs can be enriched by several markers including drug-resistant side population (SP), CD133pos and ALDHhigh. Using human non-small cell lung adenocarcinoma cell lines and patient-derived primary tumor cells, we demonstrate that SP cells represent a subpopulation distinct from other cancer stem/progenitor cell (CS/PC) populations marked by CD133pos or ALDHhigh. The non-CS/PCs and CS/PCs of each subpopulation are interconvertible. Epithelial-mesenchymal transition (EMT) promotes the formation of CD133pos and ALDHhigh CS/PC subpopulations while suppressing the SP CS/PC subpopulation. Rac1 GTPase activity is significantly increased in cells that have undergone EMT, and targeting Rac1 is effective in inhibiting the dynamic conversion of non-CS/PCs to CS/PCs, as well as the CS/PC activity. These results imply that various subpopulations of CS/PCs and non-CS/PCs may achieve a stochastic equilibrium in a defined microenvironment, and eliminating multiple subpopulations of CS/PCs and effectively blocking non-CS/PC to CS/PC transition, by an approach such as targeting Rac1, can be a more effective therapy.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$63,100 per month
Estimations show Nature.com's display ad online revenue falls between $42,042 and $115,616 per month.

Keywords {🔍}

cells, expression, cancer, figure, cspc, cell, panel, lung, emt, subpopulations, article, nscla, tgfβ, rac, google, scholar, primary, cdpos, aldhhigh, cas, nonsp, left, activity, stem, supplementary, adenocarcinoma, increased, gene, nature, facs, csc, distinct, analysis, selfrenewal, cspcs, represent, plasticity, observed, determined, mice, transition, human, cscs, tumor, isolated, stained, colonization, compared, tumors, aldhlow,

Topics {✒️}

nature portfolio hospital research foundation privacy policy liver tumor development bead-immobilized p21-binding domain advertising immune compromised nod/scid/γc−/− cancer stem/progenitor cell small-cell lung cancer social media author information authors dynamic nature marker-defined cs/pc subpopulations transient nature 0/ reprints figure 1b middle full size image nature nature 1994 nature 2004 nature 2007 nature 2010 nature 2005 aldh1a1-/cd133-/mutant p53 slow-cycling melanoma cells creative commons attribution-noncommercial cobble-stone epithelial morphology tumor-initiating cell propagation distinct cs/pc subpopulations author correspondence primary resected early-stage therapy-resistant tumor cells cs/pc subpopulations vary liver-lodged cancer cells drug-resistant side population cs/pc transition dynamically distinct cs/pc subpopulation anti-rac1 western blotting adherent sphere-forming conditions cancer stem cell middle panel multiple cs/pc subpopulations nscla cs/pc subpopulations single cs/pc subpopulations reveal relative rac1-gtp cytokine-induced killer cells stem cell marker regulate nf-κβ activity tumour cell growth initiating tumour growth

Questions {❓}

  • Cancer stem cells: mirage or reality?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity
         description:Cancer stem cells (CSCs) represent a population of cancer cells that possess unique self-renewal and differentiation characteristics required for tumorigenesis and are resistant to chemotherapy-induced apoptosis. Lung CSCs can be enriched by several markers including drug-resistant side population (SP), CD133pos and ALDHhigh. Using human non-small cell lung adenocarcinoma cell lines and patient-derived primary tumor cells, we demonstrate that SP cells represent a subpopulation distinct from other cancer stem/progenitor cell (CS/PC) populations marked by CD133pos or ALDHhigh. The non-CS/PCs and CS/PCs of each subpopulation are interconvertible. Epithelial-mesenchymal transition (EMT) promotes the formation of CD133pos and ALDHhigh CS/PC subpopulations while suppressing the SP CS/PC subpopulation. Rac1 GTPase activity is significantly increased in cells that have undergone EMT, and targeting Rac1 is effective in inhibiting the dynamic conversion of non-CS/PCs to CS/PCs, as well as the CS/PC activity. These results imply that various subpopulations of CS/PCs and non-CS/PCs may achieve a stochastic equilibrium in a defined microenvironment, and eliminating multiple subpopulations of CS/PCs and effectively blocking non-CS/PC to CS/PC transition, by an approach such as targeting Rac1, can be a more effective therapy.
         datePublished:2012-07-19T00:00:00Z
         dateModified:2012-07-19T00:00:00Z
         pageStart:e352
         pageEnd:e352
         sameAs:https://doi.org/10.1038/cddis.2012.93
         keywords:
            Non-small-cell lung cancer
            lung cancer
            cancer stem cells
            Rac1
            EMT
            self-renewal
            plasticity
            Life Sciences
            general
            Biochemistry
            Cell Biology
            Immunology
            Cell Culture
            Antibodies
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig6_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig7_HTML.jpg
         isPartOf:
            name:Cell Death & Disease
            issn:
               2041-4889
            volumeNumber:3
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:S Akunuru
               affiliation:
                     name:Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati
                     address:
                        name:Division of Experimental Hematology and Cancer Biology, Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, USA
                        type:PostalAddress
                     type:Organization
                     name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati
                     address:
                        name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati, Cincinnati, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Q James Zhai
               affiliation:
                     name:University of Cincinnati
                     address:
                        name:Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Y Zheng
               affiliation:
                     name:Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati
                     address:
                        name:Division of Experimental Hematology and Cancer Biology, Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, USA
                        type:PostalAddress
                     type:Organization
                     name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati
                     address:
                        name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati, Cincinnati, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity
      description:Cancer stem cells (CSCs) represent a population of cancer cells that possess unique self-renewal and differentiation characteristics required for tumorigenesis and are resistant to chemotherapy-induced apoptosis. Lung CSCs can be enriched by several markers including drug-resistant side population (SP), CD133pos and ALDHhigh. Using human non-small cell lung adenocarcinoma cell lines and patient-derived primary tumor cells, we demonstrate that SP cells represent a subpopulation distinct from other cancer stem/progenitor cell (CS/PC) populations marked by CD133pos or ALDHhigh. The non-CS/PCs and CS/PCs of each subpopulation are interconvertible. Epithelial-mesenchymal transition (EMT) promotes the formation of CD133pos and ALDHhigh CS/PC subpopulations while suppressing the SP CS/PC subpopulation. Rac1 GTPase activity is significantly increased in cells that have undergone EMT, and targeting Rac1 is effective in inhibiting the dynamic conversion of non-CS/PCs to CS/PCs, as well as the CS/PC activity. These results imply that various subpopulations of CS/PCs and non-CS/PCs may achieve a stochastic equilibrium in a defined microenvironment, and eliminating multiple subpopulations of CS/PCs and effectively blocking non-CS/PC to CS/PC transition, by an approach such as targeting Rac1, can be a more effective therapy.
      datePublished:2012-07-19T00:00:00Z
      dateModified:2012-07-19T00:00:00Z
      pageStart:e352
      pageEnd:e352
      sameAs:https://doi.org/10.1038/cddis.2012.93
      keywords:
         Non-small-cell lung cancer
         lung cancer
         cancer stem cells
         Rac1
         EMT
         self-renewal
         plasticity
         Life Sciences
         general
         Biochemistry
         Cell Biology
         Immunology
         Cell Culture
         Antibodies
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig6_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2012.93/MediaObjects/41419_2012_Article_BFcddis201293_Fig7_HTML.jpg
      isPartOf:
         name:Cell Death & Disease
         issn:
            2041-4889
         volumeNumber:3
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:S Akunuru
            affiliation:
                  name:Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati
                  address:
                     name:Division of Experimental Hematology and Cancer Biology, Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, USA
                     type:PostalAddress
                  type:Organization
                  name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati
                  address:
                     name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati, Cincinnati, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Q James Zhai
            affiliation:
                  name:University of Cincinnati
                  address:
                     name:Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Y Zheng
            affiliation:
                  name:Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati
                  address:
                     name:Division of Experimental Hematology and Cancer Biology, Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, USA
                     type:PostalAddress
                  type:Organization
                  name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati
                  address:
                     name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati, Cincinnati, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Death & Disease
      issn:
         2041-4889
      volumeNumber:3
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati
      address:
         name:Division of Experimental Hematology and Cancer Biology, Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, USA
         type:PostalAddress
      name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati
      address:
         name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati, Cincinnati, USA
         type:PostalAddress
      name:University of Cincinnati
      address:
         name:Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, USA
         type:PostalAddress
      name:Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati
      address:
         name:Division of Experimental Hematology and Cancer Biology, Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, USA
         type:PostalAddress
      name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati
      address:
         name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati, Cincinnati, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:S Akunuru
      affiliation:
            name:Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati
            address:
               name:Division of Experimental Hematology and Cancer Biology, Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, USA
               type:PostalAddress
            type:Organization
            name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati
            address:
               name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati, Cincinnati, USA
               type:PostalAddress
            type:Organization
      name:Q James Zhai
      affiliation:
            name:University of Cincinnati
            address:
               name:Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, USA
               type:PostalAddress
            type:Organization
      name:Y Zheng
      affiliation:
            name:Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati
            address:
               name:Division of Experimental Hematology and Cancer Biology, Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, USA
               type:PostalAddress
            type:Organization
            name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati
            address:
               name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati, Cincinnati, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Division of Experimental Hematology and Cancer Biology, Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, USA
      name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati, Cincinnati, USA
      name:Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, USA
      name:Division of Experimental Hematology and Cancer Biology, Children’s Hospital Research Foundation, Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, USA
      name:Molecular Developmental Biology Program, Children’s Hospital Research Foundation, University of Cincinnati, Cincinnati, USA

Social Networks {👍}(1)

External Links {🔗}(92)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

5.81s.